Coherus BioSciences Inc (CHRS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $81.21M
Last updated: Nov 17, 2026 at 4:38 PM ET
Coherus BioSciences Inc (CHRS) Stock Chart
Coherus BioSciences (CHRS) has a latest price of $0.48 on Nov 17, 2026. Its price fell 59.8% over the past 12 months. The month-end price fell 97.0% over the 10 years through Oct 2026, a compound annual decline of 29.5%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $28.15 in Dec 2016 and its lowest $0.73 in Jun 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart CHRS with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CHRS.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 64.0%, and over 6 months it fell 67.7%. The month-end price fell 75.2% over the 3 years through Oct 2026, a compound annual decline of 37.2%.
| Period | Change |
|---|---|
| 1 month | -50.1% |
| 3 months | -64.0% |
| 6 months | -67.7% |
| 12 months | -59.8% |
| 12 months, with dividends | -59.8% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -75.2% | -37.2% |
| 5 years | -95.0% | -45.2% |
| 10 years | -97.0% | -29.5% |
Price by Year
Its best calendar year was 2019, when the price rose 99.0%, and its weakest was 2017, when it fell 68.7%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.83 | -41.5% |
| 2025 | $1.42 | +2.9% |
| 2024 | $1.38 | -58.6% |
| 2023 | $3.33 | -58.0% |
| 2022 | $7.92 | -50.4% |
| 2021 | $15.96 | -8.2% |
| 2020 | $17.38 | -3.5% |
| 2019 | $18.00 | +99.0% |
| 2018 | $9.05 | +2.8% |
| 2017 | $8.80 | -68.7% |
Trading Range
The price is 53.2% below its 50-day average of $1.02 and 67.0% below its 200-day average of $1.45.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.48 | |
| 50-day average | $1.02 | -53.2% |
| 200-day average | $1.45 | -67.0% |
Price Risk
Over 3 years, its largest fall from a peak was 85.6%.
| Measure | Value |
|---|---|
| 1-year beta | 2.05 |
| Largest fall, 1 year | -80.9% |
| Largest fall, 3 years | -85.6% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About CHRS
What is CHRS's 1-year price change?
Coherus BioSciences's price fell 59.8% over the past 12 months. With dividends included, the 12-month total return was -59.8%.
What is CHRS's 5-year price change?
Coherus BioSciences's month-end price fell 95.0% over the 5 years through Oct 2026, a compound annual decline of 45.2%. These figures leave out dividends.
What is CHRS's beta?
Coherus BioSciences's 1-year beta against the S&P 500 is 2.05, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 80.9%.
Is the CHRS chart free?
Yes. Advanced Charting for CHRS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
CHRS pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors